Abstract:Current studies have shown that long non-coding RNAs (lncRNAs) play a crucial role in a variety of fundamental biological processes related to complex human diseases. The prediction of latent disease-lncRNA associations can help to understand the pathogenesis of complex human diseases at the level of lncRNA, which also contributes to the detection of disease biomarkers, and the diagnosis, treatment, prognosis and prevention of disease. Nevertheless, it is still a challenging and urgent task to accurately identify latent disease-lncRNA association. Discovering latent links on the basis of biological experiments is time-consuming and wasteful, necessitating the development of computational prediction models. In this study, a computational prediction model has been remodeled as a matrix completion framework of the recommendation system by completing the unknown items in the rating matrix. A novel method named faster randomized matrix completion for latent disease-lncRNA association prediction (FRMCLDA) has been proposed by virtue of improved randomized partial SVD (rSVD-BKI) on a heterogeneous bilayer network. First, the correlated data source and experimentally validated information of diseases and lncRNAs are integrated to construct a heterogeneous bilayer network. Next, the integrated heterogeneous bilayer network can be formalized as a comprehensive adjacency matrix which includes lncRNA similarity matrix, disease similarity matrix, and disease-lncRNA association matrix where the uncertain disease-lncRNA associations are referred to as blank items. Then, a matrix approximate to the original adjacency matrix has been designed with predicted scores to retrieve the blank items. The construction of the approximate matrix could be equivalently resolved by the nuclear norm minimization. Finally, a faster singular value thresholding algorithm with a randomized partial SVD combing a new sub-space reuse technique has been utilized to complete the adjacency matrix. The results of leave-one-out cross-validation (LOOCV) experiments and 5-fold cross-validation (5-fold CV) experiments on three different benchmark databases have confirmed the availability and adaptability of FRMCLDA in inferring latent relationships of disease-lncRNA pairs, and in inferring lncRNAs correlated with novel diseases without any prior interaction information. Additionally, case studies have shown that FRMCLDA is able to effectively predict latent lncRNAs correlated with three widespread malignancies: prostate cancer, colon cancer, and gastric cancer.

GCRFLDA: scoring lncRNA-disease associations using graph convolution matrix completion with conditional random field

Inferring LncRNA-disease associations based on graph autoencoder matrix completion

Prediction of lncRNA and disease associations based on residual graph convolutional networks with attention mechanism

LncRNA-Disease Association Prediction Based on Graph Neural Networks and Inductive Matrix Completion

NFMCLDA: Predicting miRNA-based lncRNA-disease associations by network fusion and matrix completion

iGRLCDA: identifying circRNA–disease association based on graph representation learning

LDGRNMF: LncRNA-disease associations prediction based on graph regularized non-negative matrix factorization

gGATLDA: lncRNA-disease association prediction based on graph-level graph attention network

GDCL-NcDA: identifying non-coding RNA-disease associations via contrastive learning between deep graph learning and deep matrix factorization

Learning Association Characteristics by Dynamic Hypergraph and Gated Convolution Enhanced Pairwise Attributes for Prediction of Disease-Related lncRNAs

Inferring Latent Disease-lncRNA Associations by Faster Matrix Completion on a Heterogeneous Network

GANLDA: Graph attention network for lncRNA-disease associations prediction

ACLNDA: an asymmetric graph contrastive learning framework for predicting noncoding RNA-disease associations in heterogeneous graphs

HRGCNLDA: Forecasting of lncRNA-disease association based on hierarchical refinement graph convolutional neural network

lncRNA-disease association prediction based on matrix decomposition of elastic network and collaborative filtering

LncRNA Expression Profile-Based Matrix Factorization for Predicting lncRNA- Disease Association

Prediction of lncRNA–disease associations based on inductive matrix completion

Graph regularized L2,1-nonnegative matrix factorization for miRNA-disease association prediction

LDAGM: prediction lncRNA-disease asociations by graph convolutional auto-encoder and multilayer perceptron based on multi-view heterogeneous networks

LGCDA: Predicting CircRNA-Disease Association Based on Fusion of Local and Global Features

Similarity-guided Graph Contrastive Learning for LncRNA-disease Association Prediction